Compare Core and Main Inc (CNM) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Core and Main Inc vs Enveric Biosciences Inc — how do they compare? Core and Main Inc trades at $44.47 (market cap $8.46B), while Enveric Biosciences Inc trades at $1.28 (market cap $5.32M). The key difference: Core and Main Inc is far larger — about 1590.2× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| CNM | ENVB | |
|---|---|---|
Market Cap | $8.46B | $5.32M |
Sector | Technology | Health |
52-Week High | $66.98 | $17.40 |
52-Week Low | $44.29 | $1.28 |
Enterprise Value | $10.76B | $408.82K |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Core & Main (CNM) trades at $44.74, down 2.44% today, amid bearish technical signals but strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $0.72 exceeding expectations, and maintains solid profitability with a 23.73% ROE. Recent news highlights municipal strength and margin gains, though residential segments face weakness. Cash flow trends improved in 2026 projections, with net cash flow rising to $142M from $7M in 2025.
The outlook is mixed: analyst consensus leans bullish with 57% buy ratings, but technical indicators signal near-term pressure. Key risks include industry headwinds like high operating costs and residential market softness. Investors should weigh strong fundamentals against current bearish momentum for entry timing.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Core and Main Inc
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
